StockMarketWire.com - Immunotherapy for cancer developer Scancell Holdings said it had appointed Samantha Paston as its head of research, and Adrian Parry as head of manufacturing.

Paston started in her role in mid-January, while Parry would start in his role on 1 Febuary.

Paston joined the company from Immunocore, where she had held several positions since June 2008, including head of T-cell cloning and group leader.

Parry was joining from Mereo BioPharma, where he was head of small molecule chemistry, manufacturing and controls.




Story provided by StockMarketWire.com